Intravenous therapy: Guidance and implications for clinical practice

Ray Higginson

doi:10.12968/bjhc.2015.21.6.264

Intravenous therapy: Guidance and implications for clinical practice

Ray Higginson^*

^*Awdur cyfatebol y gwaith hwn

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

Crynodeb

Intravenous (IV) drug administation is a common procedure requiring venous cannulation. Despite its prevalence, IV therapy has several associated risks, such as infection, phelbitis, hypervolaemia and anaphylaxis. This article provides a brief overview of current clinical guidance on IV therapy and the current challenges in terms of infection control and ensuring patient safety.

Iaith wreiddiol	Saesneg
Tudalennau (o-i)	264-268
Nifer y tudalennau	5
Cyfnodolyn	British Journal of Healthcare Management
Cyfrol	21
Rhif cyhoeddi	6
Dynodwyr Gwrthrych Digidol (DOIs)	https://doi.org/10.12968/bjhc.2015.21.6.264
Statws	Cyhoeddwyd - 2015

NDC y CU

Mae’r allbwn hwn yn cyfrannu at y Nod(au) Datblygu Cynaliadwy canlynol

Mynediad at Ddogfen

10.12968/bjhc.2015.21.6.264Trwydded: CC BY-NC-ND

Dyfynnu hyn

@article{63f88c857b0b4b12a5b619002bf870ba,

title = "Intravenous therapy: Guidance and implications for clinical practice",

abstract = "Intravenous (IV) drug administation is a common procedure requiring venous cannulation. Despite its prevalence, IV therapy has several associated risks, such as infection, phelbitis, hypervolaemia and anaphylaxis. This article provides a brief overview of current clinical guidance on IV therapy and the current challenges in terms of infection control and ensuring patient safety.",

keywords = "Clinical guidance, Infection prevention, Intravenous therapy, Patient safety",

author = "Ray Higginson",

year = "2015",

doi = "10.12968/bjhc.2015.21.6.264",

language = "English",

volume = "21",

pages = "264--268",

journal = "British Journal of Healthcare Management",

issn = "1358-0574",

publisher = "Mark Allen Healthcare",

number = "6",

}

TY - JOUR

T1 - Intravenous therapy

T2 - Guidance and implications for clinical practice

AU - Higginson, Ray

PY - 2015

Y1 - 2015

N2 - Intravenous (IV) drug administation is a common procedure requiring venous cannulation. Despite its prevalence, IV therapy has several associated risks, such as infection, phelbitis, hypervolaemia and anaphylaxis. This article provides a brief overview of current clinical guidance on IV therapy and the current challenges in terms of infection control and ensuring patient safety.

AB - Intravenous (IV) drug administation is a common procedure requiring venous cannulation. Despite its prevalence, IV therapy has several associated risks, such as infection, phelbitis, hypervolaemia and anaphylaxis. This article provides a brief overview of current clinical guidance on IV therapy and the current challenges in terms of infection control and ensuring patient safety.

KW - Clinical guidance

KW - Infection prevention

KW - Intravenous therapy

KW - Patient safety

U2 - 10.12968/bjhc.2015.21.6.264

DO - 10.12968/bjhc.2015.21.6.264

M3 - Article

AN - SCOPUS:84930826923

SN - 1358-0574

VL - 21

SP - 264

EP - 268

JO - British Journal of Healthcare Management

JF - British Journal of Healthcare Management

IS - 6

ER -

Intravenous therapy: Guidance and implications for clinical practice

Crynodeb

NDC y CU

Mynediad at Ddogfen

Ôl bys

Dyfynnu hyn